Touraj Shokati

University of Colorado Denver

Papers

1

Total Citations

49

H-Index

1

About

Dr. Touraj Shokati is a distinguished bioanalytical scientist whose research focuses on the development and application of high-throughput liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodologies for therapeutic drug monitoring and pharmacokinetics. His most impactful contribution is a landmark 2011 study, cited 49 times, which introduced a robust U-HPLC–MS/MS assay for the simultaneous quantification of mycophenolic acid and its major metabolites—mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide—in both human plasma and urine. This work provided a critical tool for optimizing immunosuppressive therapy in transplant patients, enabling precise, rapid, and reliable drug monitoring. Dr. Shokati’s methodological innovations have significantly advanced the field of clinical pharmacology, offering a model for high-sensitivity, multi-analyte assays that improve patient outcomes. His dedication to refining bioanalytical techniques underscores his role in bridging laboratory science and clinical application, making him a key figure in personalized medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
A high-throughput U-HPLC–MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine
49 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University of Colorado Denver

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago